Montana · Telemedicine
Specialized Psychiatric Care in Montana
Verigrate Health provides physician-led psychiatric consultation by telemedicine to appropriate patients who are physically located in Montana at the time of care. The practice is suited to diagnostic clarification, complex psychopharmacology, difficult treatment histories, focused second opinions, and careful review of whether medication changes are warranted.
Christian S. Monsalve, M.D., approaches the clinical record longitudinally: what was diagnosed, which treatments helped, where uncertainty remains, how prior changes were tolerated, and what should be understood before another decision is made. The result may be a recommendation to continue, revise, simplify, or gradually reduce treatment.
Longitudinal Clinical Review
Understanding the Full Course Before the Next Step
A focused second opinion when symptoms persist, diagnoses conflict, treatment response is difficult to interpret, or the next clinical step remains uncertain.
Planning for dose reduction when the medication sequence, withdrawal history, comorbid conditions, and larger treatment plan require close attention.
Review of benzodiazepine exposure, dependence, tolerance, prior withdrawal, co-prescribed medicines, clinical risk, and whether change is appropriate now.
Assessment of ongoing indication, cumulative medication burden, tolerability, interactions, and whether simplification would strengthen rather than destabilize care.
Psychiatric recommendations considered alongside sleep, metabolic risk, physical health, substance use, and other medically relevant factors.
Consultation for alcohol-related psychiatric complexity, medication strategy, evidence-based options, treatment response, and level-of-care questions.
Medication Stewardship
Psychiatric Medication Tapering in Montana
Medication reduction is considered when clinically appropriate and is not presumed to be the goal of care. The first task is often to understand the regimen: the original indication, benefit and burden over time, prior withdrawal, symptoms that followed earlier changes, concurrent treatment, and the patient’s present priorities. When a taper is appropriate, the sequence may matter as much as the final dose, especially when several medications or diagnoses are involved.
Antidepressant review may include escitalopram (Lexapro), sertraline (Zoloft), fluoxetine (Prozac), venlafaxine (Effexor XR), duloxetine (Cymbalta), bupropion, mirtazapine, and tricyclic antidepressants. Planning considers duration, prior benefit, earlier dose changes, withdrawal sensitivity, recurrence risk, and the patient’s reasons for seeking a different course.
Benzodiazepines such as alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) are evaluated in the context of duration, dependence, concurrent medicines, prior attempts to reduce, medical risk, and the reasons treatment has continued. Tapering, when appropriate, is individualized and monitored rather than reduced to a fixed schedule.
Sleep medications and hypnotics
Review may include zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), orexin receptor antagonists, sedating antidepressants, and other hypnotics. Recommendations distinguish the underlying sleep problem from medication effects, rebound insomnia, withdrawal, and coexisting psychiatric symptoms.
Antipsychotics, mood stabilizers, and ADHD medications
Antipsychotics, lithium and other mood stabilizers, stimulant and non-stimulant ADHD treatments, anxiolytics, adjunctive medicines, and medications used in substance-related care may also be reviewed. The aim is to understand the complete system of treatment before deciding what, if anything, should change.
Sequence Before Speed
In a complex regimen, the first decision may be what not to change. Recommendations distinguish medication effects, withdrawal, recurrence, and unrelated symptoms while preserving useful treatment wherever possible.
How Care Works
Specialist Psychiatric Consultation Across Montana by Telemedicine
Appropriate patients may receive focused psychiatric consultation by secure telemedicine while physically located in Montana at the time of the visit. Telemedicine can create access to a detailed specialist review without implying a local office or in-person service. The work may address unresolved diagnosis, complex medication histories, deprescribing, or a proposed taper while another clinician remains involved when appropriate. Verigrate is not an emergency service, and availability depends on clinical fit and practice capacity.
Practice Structure
Common Questions
Can patients in Montana meet with Verigrate by telemedicine?
Yes. Appropriate patients may receive physician-led psychiatric consultation by secure telemedicine while physically located in Montana at the time of care. Verigrate does not claim a physical Montana office, hospital affiliation, or walk-in service.
When is a complex psychiatric consultation useful?
It may be useful when diagnoses remain uncertain, several medications have been tried, treatment effects are difficult to separate from withdrawal or adverse effects, or a patient and treating clinician need a careful second look before the next decision.
Can a long medication history be reconstructed?
Yes. The evaluation can organize medication sequence, duration, response, adverse effects, overlapping changes, withdrawal experiences, prior diagnostic reasoning, and relevant records. The goal is to identify what the history actually supports rather than assume the newest explanation is correct.
Does consultation require discontinuing psychiatric medication?
No. Medication reduction is not a condition of care. A sound recommendation may be to continue the current regimen, gather more information, change one element, simplify treatment, delay a taper, or proceed gradually when the expected benefit justifies the risk.
How does an initial Montana consultation begin?
It begins with the central clinical question and a detailed review of symptoms, diagnoses, current treatment, prior medication trials, withdrawal experiences, relevant medical factors, and available records. Dr. Monsalve then discusses what can be clarified, what remains uncertain, and which next steps are clinically appropriate.